Fluxion Biosciences provides analytical, live cell analysis tools that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms in physiologically relevant micro-environments, Fluxion helps bridge the translational medicine gap by bringing research data closer to patients. Fluxion's innovative systems for live cell analysis are enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Formerly known as Fluxar Inc.
Cell Microsystems acquired Fluxion Biosciences on August 23, 2023.